Welcome to our dedicated page for Sintx Technologies SEC filings (Ticker: SINT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SINTX Technologies, Inc. filings document an advanced ceramics and biomaterials issuer focused on silicon nitride medical technologies, including formal disclosures on operating results, regulatory communications, capital formation, and governance. Recent Form 8-K reports cover quarterly financial results and Regulation FD disclosures tied to FDA 510(k) activity for silicon nitride foot and ankle medical devices.
The company’s SEC record also includes an at-the-market common stock offering agreement, officer appointment and executive compensation disclosures, and a definitive proxy statement for annual meeting voting. These filings describe board and stockholder matters, material agreements, common stock issuance mechanics, and formal disclosure topics connected to SINTX’s medical-device commercialization and biomaterials platform.
SINTX Technologies (SINT) filed a Form 4 reporting an insider purchase. The company’s President and CEO, who also serves as a director, purchased 5,800 shares of common stock on 10/20/2025 at a price of $3.4 per share.
Following this transaction, the reporting person beneficially owns 30,775 shares, held directly. The filing indicates it was submitted by one reporting person.
SINTX Technologies established an at-the-market stock offering program to sell common shares with an aggregate offering price of $6,413,876 through H.C. Wainwright as sales agent. The program uses the company’s effective Form S-3 shelf registration and a new prospectus supplement.
Wainwright will receive a 3.0% commission on the gross sales price of any shares sold, plus reimbursement of specified expenses. SINTX is not required to sell any stock, can suspend the program at any time, and will designate the maximum amount of stock to be sold in each placement.
Sintx Technologies, Inc. filed a prospectus supplement for a securities offering that discloses pro forma tangible book value and recent capital-raising activity. As of June 30, 2025 the company reported a net tangible book value per share of $1.60. Following the issuance of 723,873 shares in a warrant inducement offering that closed on September 8, 2025 for net proceeds of approximately $3.35 million, pro forma net tangible book value per share rose by $0.68 to $2.28. The current offering would further increase pro forma net tangible book value per share by $0.53, producing a pro forma as adjusted value of $2.81 per share and resulting in dilution to new investors of $1.28 per share.
The document contains table-of-contents material and references to incorporated filings and exhibits but does not provide full disclosure of the total shares outstanding immediately after the offering or detailed use-of-proceeds amounts in the excerpt provided.
SINTX Technologies, Inc. filed a Form S-8 registration statement to register shares of its common stock for issuance under the SINTX Technologies, Inc. 2025 Equity Incentive Plan. This filing allows the company to grant equity-based awards, such as stock options or other share-based incentives, to eligible participants.
The registration statement incorporates by reference SINTX’s recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and multiple Current Reports on Form 8-K, along with the description of its common stock. It also details Delaware-law based indemnification and exculpation protections for directors and officers and lists numerous warrant and indenture forms as exhibits. The document is signed by the Chief Executive Officer, Chief Financial Officer, and the board of directors.
SINTX Technologies, Inc. is registering 541,450 shares of common stock for resale by a single selling stockholder under an S-3 prospectus. The shares include 216,450 PIPE Shares issued in a private placement and 325,000 Warrant Shares issuable upon exercise of common warrants.
SINTX will not sell any shares in this offering and will not receive proceeds from the stockholder’s resales. It could receive up to approximately $2.05 million only if all 325,000 warrants are exercised for cash at an exercise price of $6.30 per share. As of September 26, 2025, 3,585,856 shares of common stock were outstanding, rising to 3,910,856 shares if all these warrants are exercised.
The company develops advanced silicon nitride ceramics for biomedical and antipathogenic uses, including spinal implants and osteotomy wedges, and notes that investing in its securities involves a high degree of risk, including potential dilution and stock price pressure from warrant-related share sales.
SiNtx Technologies, Inc. disclosed an agreement allowing holders to exercise existing warrants and receive new common stock purchase warrants. The holders may exercise existing warrants to acquire shares at $3.32 per share, and the company will issue New Warrants to purchase up to 1,649,147 common shares at $4.79 per share. Holders also agreed to pay $0.125 per New Warrant as consideration. The company expects to receive aggregate gross proceeds of approximately $3.8 million from exercise of the existing warrants, before placement agent fees and other offering expenses. The filing includes forms for the inducement letter, New Warrant, placement agent warrants and related exhibits, and is signed by CEO Eric K. Olson.
Sintx Technologies reported a grant of 70,000 restricted stock units (RSUs) to Kevin Trask, the company’s Chief Financial Officer, on 09/04/2025. The RSUs were issued under the 2025 Equity Incentive Plan and represent the contingent right to receive one share per RSU upon vesting. Twenty percent of the award vested immediately, and the remainder vests at 20% every six months thereafter. After the grant, Mr. Trask beneficially owns 90,000 shares of common stock.
Kevin Trask, Chief Financial Officer of SiNtx Technologies, Inc. (SINT) filed an Initial Statement of Beneficial Ownership (Form 3) reporting direct ownership of 4,376 shares of common stock and 20,000 restricted stock units (RSUs). The RSUs were granted under the 2020 Equity Incentive Plan, with 25% immediately vested and the remainder vesting over three years. The filing is dated 09/04/2025 and was signed by Kevin Ontiveros by power of attorney.
Kevin Patrick Murphy reports beneficial ownership of 225,914 shares of Sintx Technologies, Inc., representing 8.2% of the outstanding common stock based on an outstanding share count of 2,758,865. The disclosed position consists of 138,957 shares of common stock and 86,957 warrants to purchase common stock, and the filer reports sole voting and sole dispositive power over the full amount. The filing states the securities were not acquired to change or influence control of the issuer. The statement is filed on behalf of an individual reporting person, Kevin Patrick Murphy, who identifies as a U.S. citizen.
Jay M. Moyes, a director of SiNtx Technologies, Inc. (SINT), reported a purchase of 3,000 shares of common stock on 08/26/2025 at a reported price of $3.5854 per share. Following the transaction, he beneficially owns 3,000 shares directly. The Form 4 was signed under power of attorney on 08/27/2025. No derivative transactions or additional holdings were reported.